# Why a Global Health Plan Costs $500 and a US Plan Costs $1,200: The Four Things the Price Tag Hides The cheap international plan and the expensive US plan are not the same product. The global one usually excludes the US, screens out the sick, and pays lower prices everywhere else. Author: J.A. Watte Published: July 16, 2026 Source: https://jwatte.com/blog/international-vs-us-health-insurance-cost/ --- Browse an international health-insurance comparison site and you will find something that looks like an indictment of American medicine. A healthy individual can buy a comprehensive global plan for something like 400 to 500 dollars a month, with a low deductible or none at all, covering hospitals and specialists across dozens of countries. The same person shopping the United States individual market can easily face 1,000 dollars a month or more, with a deductible of several thousand on top. Same customer, same body, wildly different price. It is tempting to conclude that American insurers are simply gouging, and there is a real grain of truth in that. But the comparison is not apples to apples, and the gap is almost entirely explained by four specific mechanisms stacked on top of each other. Understanding them tells you a great deal about how American health care actually works, and why the cheap global plan is not the deal it appears to be for anyone who plans to get sick in the United States. ## Mechanism one: the cheap plan usually does not cover the United States Start with the single biggest lever, the one that breaks the comparison before you even reach the medicine. International private medical insurance is priced by "area of cover," and the most expensive area to include, by far, is the United States. These plans are typically sold in versions like "worldwide" and "worldwide excluding the USA," and the difference between them is enormous. Major carriers including APRIL, Allianz Care, and AXA all offer a US-excluded coverage area precisely because dropping the United States slashes the premium, commonly by 20 to 40 percent, while US-inclusive worldwide coverage can run to 28,000 dollars a year or more ([InternationalInsurance.com](https://www.internationalinsurance.com/health/); [Allianz Care](https://www.allianzcare.com/en/about-us/blog/what-can-lower-an-international-health-insurance-premium.html)). APRIL states the mechanism outright, that it can exclude medical cover in the United States to reduce the cost of the plan ([APRIL International](https://www.april-international.com/en/long-term-international-health-insurance/guide/how-much-does-international-health-insurance-cost)). So the sub-600-dollar plan you are comparing against your American premium very likely does not cover you if you get treated in the United States, or covers only emergencies there on the better tiers. It is built for an expatriate who lives and gets care in Thailand, Portugal, or Mexico, and who, if they needed a major operation, would have it done somewhere the price is a fraction of the American one. That is not a comprehensive American health plan sold cheaply. It is a different product that has deliberately routed itself around the most expensive health system on earth. Which raises the obvious question of why the American system is that expensive. ## Mechanism two: American medical prices are the highest in the world The United States spends about twice as much per person on health care as comparable wealthy nations, roughly 13,432 dollars a head in 2022 against a peer-country average of 7,393 ([Peterson-KFF Health System Tracker](https://www.healthsystemtracker.org/chart-collection/how-do-healthcare-prices-and-use-in-the-u-s-compare-to-other-countries/)). The crucial finding, replicated for two decades, is why. It is not that Americans use more health care. By most measures they use less: fewer doctor visits, shorter hospital stays, and fewer physicians, nurses, and hospital beds per capita than the peer median. The gap is about prices. As the health-economics literature has put it bluntly since 2003 and again in a 2019 update, it is the prices, and Americans pay far more for the identical service ([Health Affairs, "It's Still The Prices, Stupid"](https://www.healthaffairs.org/doi/10.1377/hlthaff.2018.05144)). The specifics are stark. A landmark 2018 study in the Journal of the American Medical Association found the United States spent nearly double what ten other high-income countries did, driven by higher prices for labor and goods and by administrative costs, not by greater use; American per-capita pharmaceutical spending was 1,443 dollars against a peer average of 749, and administrative costs consumed about 8 percent of health spending against roughly 3 percent in peer nations ([JAMA](https://jamanetwork.com/journals/jama/fullarticle/2674671)). Drugs are the sharpest example: a 2024 RAND analysis for the federal government found American drug prices average 2.78 times those in 33 comparison countries, and 4.22 times for brand-name drugs, though US generics are actually cheaper ([RAND](https://www.rand.org/pubs/research_reports/RRA788-3.html)). And on procedures, the insurers' own international price comparison shows a coronary bypass costing 89,094 dollars in the United States against 10,734 in Spain, more than eight times as much, and a vial of the insulin Lantus costing 412 dollars in the US against 55 in Greece ([International Federation of Health Plans](https://ifhp.com/international-healthcare-cost-comparison-report-2024/), an insurer industry association reporting median claims its member plans actually paid). This is why an insurer that covers the United States must charge so much more. Its expected claims are denominated in American prices. An insurer that excludes the United States pays the low prices that prevail everywhere else, so it can charge a low premium for the same nominal coverage. The premium difference is, to a first approximation, just the price difference of the care being insured. ## Mechanism three: the cheap plan can refuse you; the American plan cannot The third mechanism is the one the low premium hides most completely, and it is about who is allowed to buy each product. International private medical insurance is, with few exceptions, medically underwritten. When you apply, the insurer reviews your health, and it can accept you, accept you but permanently exclude a pre-existing condition, accept you at a loaded-up premium, or decline you altogether. Cigna Global, a major carrier, uses full medical underwriting on all its policies, and applicants with significant chronic conditions are sometimes simply denied ([resource on IPMI pre-existing conditions](https://www.internationalinsurance.com/resources/pre-existing-conditions.php)). The cheap plan is cheap partly because its pool is healthy by construction: the sick and the high-risk have been screened out or had their expensive conditions carved away. The American individual market is the opposite by law. Under the Affordable Care Act, individual-market plans are guaranteed issue with community rating: the insurer cannot medically underwrite you, cannot exclude your pre-existing conditions, and cannot charge you more because you are sick. Premiums can vary only by age, within a band capped at three to one, plus tobacco use, family size, and geography ([KFF](https://www.kff.org/affordable-care-act/)). A sixty-year-old with diabetes and a cancer history pays the same rating-band price as a healthy sixty-year-old, and cannot be turned away. That protection is enormously valuable to the people who need it, and it is also expensive, because the insurer must cover everyone who shows up, including the people an underwritten global plan would have politely declined. You are not just buying insurance in the American market. You are buying into a pool that is legally required to include the sickest and the oldest. ## Mechanism four: the American plan is required to be richer The fourth mechanism is the mandated floor of the American plan. The Affordable Care Act requires individual plans to cover ten categories of essential health benefits, to provide a long list of preventive services at no cost sharing, to meet minimum actuarial-value tiers from bronze at about 60 percent to platinum at about 90 percent, to spend at least 80 percent of premiums on actual care under the medical-loss-ratio rule, and to cap an enrollee's annual in-network out-of-pocket spending, which for 2025 was 9,200 dollars for an individual ([HealthCare.gov](https://www.healthcare.gov/coverage/what-marketplace-plans-cover/); [HealthCare.gov out-of-pocket maximum](https://www.healthcare.gov/glossary/out-of-pocket-maximum-limit/)). International plans are bound by none of that. They can offer thinner or more customizable benefit packages, run different loss ratios, and structure cost sharing however they like. Some of the American premium is buying a guaranteed comprehensiveness and a guaranteed backstop against catastrophic cost that the cheap plan is not required to include, and often does not. ## The deductible, and the real trade-off That leaves the deductible, and here the premise contains a genuine trade-off rather than a contradiction. American plans deliberately use deductibles to hold premiums down against those high underlying prices. A plan can lower your monthly bill by making you pay more before coverage kicks in, and marketplace silver plans commonly carry deductibles of several thousand dollars, higher than the roughly 1,800-dollar average deductible in employer coverage ([Peterson-KFF on the premium-deductible trade-off](https://www.healthsystemtracker.org/brief/higher-premium-payments-or-higher-deductibles-the-tradeoffs-aca-enrollees-face/)). It is worth noting the 2,000-dollar deductible in the framing is typical, not universal: gold and platinum plans, and the cost-sharing-reduction silver plans available to lower-income enrollees, carry much lower or even zero deductibles in exchange for a higher premium. The global plan, by contrast, often manages both a low premium and a low deductible at once. It can do that because it stacks the other three advantages: it pays low non-US prices, it has underwritten away the expensive risks, and it assumes that major care, if needed, happens somewhere cheaper than the United States. Low premium and low deductible are not evidence that the global plan is simply a better deal. They are evidence that it is insuring a healthier person, in cheaper countries, against a smaller set of obligations. ## Two things that are both true The honest conclusion holds two ideas at once, and refuses to collapse into either. The first is that the United States genuinely overpays for medical care, by a factor of roughly two against its peers, for reasons that are about prices and market power rather than about Americans consuming more. The cheap global premium is a real market signal of that excess: the same person's care can be insured for a fraction of the price the moment you route it away from American providers. Anyone who tells you US health costs are not a scandal has not looked at the bypass that costs eight times more than it does in Spain. The second is that the features making American individual coverage expensive are not all waste. Guaranteed issue, community rating, the essential-benefit floor, and the out-of-pocket cap are a deliberately purchased protection for the old and the sick, the exact people the cheap underwritten plan screens out. The sub-600-dollar global plan is affordable in large part because it excludes the highest-cost country, excludes the highest-cost patients, and assumes the cheapest venue for care. It is a fine product for a young, healthy, mobile person who will get care abroad. It is not the plan that will still be there, at that price, for the same person at sixty-five with a heart condition, in an American hospital. The price tag is real. So is everything it leaves out. ## Related reading - [When the bills rise faster than the raise](/blog/defend-your-wage-low-growth-corridors/): the practical playbook for the American health, insurance, and energy costs this piece explains. - [COLA versus the merit raise](/blog/cola-vs-w2-wages/): the medical wedge inside a paycheck, where the employer premium is compensation you never see as cash. - [The working ledgers](/blog/the-working-ledgers/): the series on reading who pays, who collects, and what a price tag hides. ## Fact-check notes and sources Every figure was checked against a primary or authoritative source; links are inline, and broker and vendor figures are labeled as illustrations. - **US prices and spending** (about 13,432 dollars per capita in 2022 against a 7,393 peer average, with the gap driven by prices rather than utilization; the JAMA 2018 finding of nearly double spending, pharmaceutical spending of 1,443 against 749 dollars, and administrative costs of about 8 percent versus 3 percent; the "It's Still The Prices, Stupid" update; US drug prices at 2.78 times peers; and the iFHP procedure and drug comparisons): the [Peterson-KFF Health System Tracker](https://www.healthsystemtracker.org/chart-collection/how-do-healthcare-prices-and-use-in-the-u-s-compare-to-other-countries/), [JAMA](https://jamanetwork.com/journals/jama/fullarticle/2674671), [Health Affairs](https://www.healthaffairs.org/doi/10.1377/hlthaff.2018.05144), [RAND](https://www.rand.org/pubs/research_reports/RRA788-3.html), and the [International Federation of Health Plans](https://ifhp.com/international-healthcare-cost-comparison-report-2024/), the last an insurer industry association reporting member-plan median claims. - **The international-plan structure** (area-of-cover pricing with US exclusion cutting premiums roughly 20 to 40 percent and US-inclusive plans reaching 28,000 dollars a year; US-excluded coverage areas across major carriers; representative sub-600-dollar premiums for young, healthy, US-excluded applicants; and medical underwriting that can decline, exclude, or load applicants): [InternationalInsurance.com](https://www.internationalinsurance.com/health/), [Allianz Care](https://www.allianzcare.com/en/about-us/blog/what-can-lower-an-international-health-insurance-premium.html), [APRIL International](https://www.april-international.com/en/long-term-international-health-insurance/guide/how-much-does-international-health-insurance-cost), and a [resource on IPMI pre-existing conditions](https://www.internationalinsurance.com/resources/pre-existing-conditions.php). These are broker and vendor sources and their price figures are illustrative of a stated profile, not audited averages. - **The US rules and prices** (Affordable Care Act guaranteed issue, community rating with a 3-to-1 age band, the ten essential health benefits, the medical-loss-ratio and actuarial-value requirements, and the 2025 out-of-pocket maximum of 9,200 dollars for an individual; employer premiums of 26,993 dollars for family and 9,325 for single coverage in 2025 with an average single deductible near 1,886 dollars; and the premium-deductible trade-off with marketplace silver deductibles running higher): [KFF](https://www.kff.org/affordable-care-act/), [HealthCare.gov](https://www.healthcare.gov/coverage/what-marketplace-plans-cover/), the [2025 KFF Employer Health Benefits Survey](https://www.kff.org/health-costs/2025-employer-health-benefits-survey/), and the [Peterson-KFF trade-off brief](https://www.healthsystemtracker.org/brief/higher-premium-payments-or-higher-deductibles-the-tradeoffs-aca-enrollees-face/). Employer-plan deductibles are lower than individual-marketplace deductibles and are not interchangeable. *This post is informational and journalistic, not insurance, financial, or medical advice, and it is not a recommendation of any specific plan or carrier. Program rules and prices change, and subsidies can lower net US premiums for eligible enrollees. Figures are drawn from peer-reviewed research, government and foundation data, and industry and broker sources, with the last labeled as illustrative.* --- Canonical HTML: https://jwatte.com/blog/international-vs-us-health-insurance-cost/ RSS: https://jwatte.com/feed.xml JSON Feed: https://jwatte.com/feed.json Hero image: https://jwatte.com/images/international-vs-us-health-insurance-cost.webp